Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV
Status:
Completed
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the acceptability, perceived need and uptake of
short-term episodic Pre-Exposure Prophylaxis (PrEP) for HIV prevention among men who have sex
with men (MSM). The overall objective is to determine the feasibility of a clinic-based
Epi-PrEP implementation pilot project for 50 MSM (25/each of the 2 study sites) who report
occasional condomless sex and who anticipate a period of high-risk while away from home (e.g.
vacation) during the study period.
Phase:
N/A
Details
Lead Sponsor:
James Egan Ronald Stall
Collaborators:
Fenway Community Health National Institute of Mental Health (NIMH)
Treatments:
Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir